Intellipharmaceutics International Inc. Quarterly Employee-related Liabilities, Current in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Intellipharmaceutics International Inc. quarterly Employee-related Liabilities, Current history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Employee-related Liabilities, Current for the quarter ending August 31, 2023 was $3.73M, a 31% increase year-over-year.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3.73M +$882K +31% Aug 31, 2023 6-K 2023-10-16
Q2 2023 $3.49M +$821K +30.7% May 31, 2023 6-K 2023-09-26
Q1 2023 $3.31M +$858K +35% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $3.07M +$804K +35.5% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $2.85M +$818K +40.3% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $2.67M +$594K +28.6% May 31, 2022 6-K 2022-07-21
Q1 2022 $2.45M +$681K +38.4% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $2.26M +$599K +36% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $2.03M +$776K +61.9% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $2.08M +$449K +27.5% May 31, 2021 6-K 2021-07-15
Q1 2021 $1.77M +$321K +22.1% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $1.67M +$771K +86.3% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $1.25M +$1.02M +430% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $1.63M +$1.39M +590% May 31, 2020 6-K 2020-07-15
Q1 2020 $1.45M +$1.24M +575% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $894K +$671K +302% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $236K +$19.5K +9% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $236K +$12.4K +5.53% May 31, 2019 6-K 2019-07-10
Q1 2019 $215K Feb 28, 2019 6-K 2019-04-15
Q4 2018 $222K +$7.5K +3.49% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $217K Aug 31, 2018 6-K 2018-10-15
Q2 2018 $224K May 31, 2018 6-K/A 2018-07-24
Q4 2017 $215K Nov 30, 2017 6-K 2018-10-15
Q4 2015 $175K -$6.03K -3.33% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $181K -$327K -64.4% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $198K Feb 28, 2014 6-K 2014-04-14
Q4 2013 $509K -$155K -23.3% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $663K -$72.9K -9.9% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $736K +$160K +27.9% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $576K Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.